Since 1951 certain American workers have been using ultrasonic techniques in the study of blood coagulation (Yesner, Hurwitz, Rich, Roth, and Gordon, 1951; Roth and Rich, 1953; Levine, Luby, Rauch, and Yesner, 1954; Harrower, Hurwitz, and Yesner, 1958; Hurwitz, Yesner, and Cooke, 1952) . The effect of intravenous heparin (Harrower et al., 1958; Hurwitz et al., 1952) and the influence of stress on the coagulation patterns of psychotic patients (Levine et al., 1954) have been studied using this method, but apparently no otherwork has been done in this field and no comparison or correlation made with other methods. We have used an ultrasonic apparatus for the precise and continuous measurement of plasma and whole blood viscosity. The results obtained when the technique was applied to blood coagulation were compared with those from the thrombo-elastograph and it became apparent that it might usefully be applied to the study of fibrinolytic activity.
PRINCIPLE
Viscosity is that property of a liquid that resists flow. The original viscosity of whole blood changes rapidly when coagulation begins, and this change in viscosity can be followed continuously by means of the ultrasonic viscometer.2 The apparatus consists of an ultrasonic generator and a probe, used in conjunction with a computer which gives a dial reading in terms of viscosity and density of the fluid being tested. The computer can also be connected to a recorder and in this way a continuous recording of the viscosity can be obtained ( Figs. 1 and 2 ). The sensitive element is a 'blade' of stainless steel (Fig. 3) , butt-welded to a length of magnetostrictive material. The blade is 4 in. long x 0 085 in. thick x 0-125 in. wide. It is silver-soldered near its centre to a diaphragm through which is passes, which is also the end of the probe shank. As the probe is immersed in more viscous fluids, the computer automatically responds to the increased damping by increasing the repetition rate of the pulses, so that the energy in the damped oscillations remains constant. This change in pulsefrequency, which is read from the meter, is proportional to the square root of viscosity times the density in Newtonian materials. It should be noted that while the pulse repetition rate changes with viscosity, the resonant frequency of the probe blade does not change. Furthermore, there is no lateral movement of the blade whatsoever.
MATERIALS AND METHOD
The probe was supported vertically in a rigid stand (Fig. 4) , so that the blade was suspended in a small test-tube containing 4 ml. of blood. The tube was maintained at 37°C. by a thermostat and surrounded by an insulating box to reduce cooling. Parallel measurements with the thrombo-elastograph3 were made for comparison. In the experiments with fibrinolytic activators, 0-5 ml. of saline or saline containing the activator was immediately added to a 4-5 ml. blood sample in a disposable plastic syringe. Figure 6 shows the readings obtained after adding varying quantities of varidase to whole blood. Parallel thrombo-elastograms are also shown. Small quantities of varidase show no visible effect on the thrombo-elastogram and with larger quantities the trace is barely readable. The ultrasonic trace, however, shows readable changes at the lower concentration, while with the higher, a useful trace is still obtained.
RESULTS

REPRODUCIBILITY
Figures 7 and 8 show similar results using urokinase. As the concentration of activator is increased, the thrombo-elastogram shows dramatic changes, but when measured by the ultrasonic technique the changes are more progressive and more easily interpreted. Urokinase, between 0 and 1,000 units dissolved in 0 5 ml. of physiological saline and added to 4-5 ml. of native blood, showed no effect on the thromboelastograph in low concentration. No DR. PEETERS replied that the basic cost was about £900, and with a recorder about £1,200. DR. STERN stated that he had studied psychotic patients with the Ultraviscoson and found that the results were affected by the adhesiveness of the clot. Platelet-rich and platelet-poor plasma gave differently shaped curves. He felt that, while the apparatus was extremely useful in homogeneous systems, it should be supplemented by other methods when studying coagulation phenonema in patients. DR. PEETERS replied that he had overcome this difficulty by using smaller quantities of blood, better adhesion to the blade being obtained with small clots. DR. LACK warned against investing hundreds of pounds in expensive apparatus, because he had information about a new method for measuring clot For the measurement of plasminogen, probably the best method available was the caseinolytic technique, but variations in the preparation of the casein would affect the results. At present there was no standard preparation of casein available and the standardization of this reagent would be most desirable. Similar problems were encountered in the assay of plasmin.
A satisfactory method for measuring anti-plasmin did not exist at present because there was no standard plasmin preparation free from contamination with activator. This means that any plasminogen present in the test solution will be activated, causing spurious results. There was at present no satisfactory method for measuring anti-activator, and this too would appear to be a field where methodological contributions remain to be made.
Finally the most difficult and important assay of all was that of activator. There are no really satisfactory techniques available for the assay of streptokinase, blood activator, or tissue activator, since all depend on the conversion of plasminogen to plasmin and therefore measure the plasmin so produced. DR. MACFARLANE emphasized the difference between the behaviour of fibrinolysis in vitro and its possible behaviour in vivo, pointing out that laboratory experiments had no counterpart in the body. For example, nobody has passed blood over a surface for a great many years as happens in the circulation. DR. EMERY felt that the object was perhaps to prevent clots forming rather than to lyse them after they had formed. DR. STEWART, agreeing, stated that, in their experience, if activator is used quickly it can prevent fibrin formation, but that fibrin which has been deposited for more than a few days is extremely difficult to lyse. DR. McNICOL stated that he had developed an artificial circulation made of glass, in which a clot could be subjected to a lytic solution pumped round the system. In those circumstances a clot, which would take days to lyse in a test tube, could lyse quite quickly. DR. MACFARLANE reminded the meeting of the differences between a clot and a thrombus and asked what happened to a platelet thrombus when it was exposed to fibrinolytic agents? DR. McNICOL stated that as a result of a few experiments it would appear that a platelet-rich thrombus, in fact consisting largely of platelet material, could be lysed in vitro with streptokinase.
